Efficacy of a new calcium antagonist PN 200-110 (Isradipine) in angina pectoris
- 30 January 1987
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 59 (3) , B123-B129
- https://doi.org/10.1016/0002-9149(87)90091-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Selective effects of PN 200-110 (isradipine) on the peripheral circulation and the heartThe American Journal of Cardiology, 1987
- Cardioprotection by the calcium antagonist PN 200-110 in the absence and presence of cardiodepressionBritish Journal of Pharmacology, 1985
- Effects of the New Calcium Antagonist PN 200–110 on the Myocardium and the Regional Peripheral Circulation in Anesthetized Cats and DogsJournal of Cardiovascular Pharmacology, 1984
- PN 200–110, A New Calcium AntagonistJournal of Cardiovascular Pharmacology, 1984
- Safety, tolerability and efficacy of PN 200-110, a new calcium antagonist in patients with angina and coronary heart diseaseEuropean Journal of Clinical Pharmacology, 1984
- Objective evaluation of three dose levels of diltiazem in patients with chronic stable anginaJournal of the American College of Cardiology, 1983
- Clinical Evaluation of Verapamil in Angina PectorisBMJ, 1968